Medications for Treatmentresistant Depressive Disorder

16 results

  • Fluoxetine (fluoxetine hydrochloride)

    (Fluoxetine Hydrochloride)
    Northwind Pharmaceuticals
    Usage: Fluoxetine is indicated for treating Major Depressive Disorder, Obsessive Compulsive Disorder, moderate to severe Bulimia Nervosa, and Panic Disorder. When combined with Olanzapine, it treats depressive episodes in Bipolar I Disorder and treatment-resistant depression. Monotherapy with fluoxetine is not for Bipolar I or treatment-resistant depression.

  • Fluoxetine (fluoxetine hydrochloride)

    (Fluoxetine Hydrochloride)
    Aurobindo Pharma Limited
    Usage: Fluoxetine capsules are indicated for the acute and maintenance treatment of Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia Nervosa, and Panic Disorder. Additionally, in combination with Olanzapine, they treat depressive episodes in Bipolar I Disorder and treatment-resistant depression.

  • Fluoxetine (fluoxetine)

    (Fluoxetine)
    Cadila Pharmaceuticals Limited
    Usage: Fluoxetine capsules are indicated for treating Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia Nervosa, and Panic Disorder. They can be combined with Olanzapine for Bipolar I Disorder and Treatment Resistant Depression. Monotherapy is not approved for Bipolar I or treatment-resistant cases.

  • Olanzapine (olanzapine)

    (Olanzapine)
    Ascend Laboratories, LLC
    Usage: Oral olanzapine is indicated for treating schizophrenia and bipolar I disorder (acute manic or mixed episodes). It may be used alone or as an adjunct to lithium or valproate. Additionally, it's indicated in combination with fluoxetine for depressive episodes in bipolar I disorder and treatment-resistant depression.

  • Olanzapine (olanzapine)

    (Olanzapine)
    Macleods Pharmaceuticals Limited
    Usage: Olanzapine orally disintegrating tablets are indicated for the treatment of schizophrenia, bipolar I disorder (both manic/mixed episodes and as adjunctive therapy), depressive episodes associated with bipolar I disorder (in combination with fluoxetine), and treatment-resistant depression (also with fluoxetine). Caution is advised in pediatric patients due to potential risks.

  • Olanzapine (olanzapine)

    (Olanzapine)
    Teva Pharmaceuticals USA, Inc.
    Usage: Olanzapine orally disintegrating tablets are indicated for the treatment of schizophrenia and bipolar I disorder (manic or mixed episodes). Additionally, they are used in combination with fluoxetine for depressive episodes associated with bipolar I disorder and treatment-resistant depression. Efficacy has been demonstrated in clinical trials for both adults and adolescents.

  • Olanzapine (olanzapine)

    (Olanzapine)
    Quality Care Products, LLC
    Usage: Olanzapine is indicated for the treatment of schizophrenia and bipolar I disorder (both manic/mixed episodes and maintenance). It can also be used in combination with fluoxetine for depressive episodes associated with bipolar I disorder and treatment-resistant depression. Caution is advised for pediatric patients due to potential risks.

  • Olanzapine (olanzapine)

    (Olanzapine)
    Golden State Medical Supply, Inc.
    Usage: Olanzapine is indicated for treating schizophrenia and bipolar I disorder (manic or mixed episodes), both in adults and adolescents. It's also approved for use in combination with fluoxetine for depressive episodes related to bipolar I disorder and treatment-resistant depression.

  • Olanzapine (olanzapine)

    (Olanzapine)
    REMEDYREPACK INC.
    Usage: Olanzapine is indicated for the treatment of schizophrenia and bipolar I disorder (manic or mixed episodes), both as monotherapy and adjunctive therapy. It is also used in combination with fluoxetine for depressive episodes in bipolar I disorder and treatment-resistant depression. Consideration for risks is advised, especially in adolescents.

  • Olanzapine (olanzapine)

    (Olanzapine)
    REMEDYREPACK INC.
    Usage: Oral olanzapine is indicated for the treatment of schizophrenia and bipolar I disorder (acute and maintenance). It is effective in adult and adolescent patients. Additionally, it can be used in combination with fluoxetine for depressive episodes in bipolar I disorder and treatment-resistant depression.